title: Effect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeys.
abstract: Drug abuse can be conceptualized as excessive choice of drug over other reinforcers, and factors that affect drug taking can be examined experimentally using choice procedures. This study examined the impact of reinforcer delay on self-administration of the μ-opioid receptor agonist remifentanil in rhesus monkeys (n = 4) lever pressing under a concurrent fixed-ratio 30 schedule. Responding on either lever delivered an intravenous infusion of either remifentanil or saline. Dose-effect curves were first determined when responding on one lever delivered remifentanil and responding on a second lever delivered saline. Monkeys then chose between two doses of remifentanil, and delay to delivery of the large dose was varied systematically. Responding for remifentanil (0.01-1.0 µg/kg/infusion) increased dose-dependently when the alternative was saline or a dose of remifentanil. Delaying delivery of the large dose of remifentanil by 30, 60, 120, or 240 seconds increased responding for smaller, immediately available doses (0.01-0.1 µg/kg/infusion) and, in some cases, increased responding for doses of remifentanil that did not maintain responding when the alternative was saline. These data demonstrate that delaying the delivery of an opioid receptor agonist can significantly affect its reinforcing effectiveness. The imposition of a delay reduces the effectiveness of large doses of drug to maintain responding and increases the effectiveness of immediately available commodities, including smaller doses of drug. Increased reinforcing effectiveness of smaller doses of drug in the context of other delayed reinforcers might contribute to the development and maintenance of opioid abuse.
authors.affiliation: Departments of Pharmacology (D.R.M., L.R.G., C.P.F.) and Psychiatry (C.P.F.), the University of Texas Health Science Center at San Antonio, San Antonio, Texas.
authors.forename: David R
authors.initials: DR
authors.lastname: Maguire
authors.forename: Lisa R
authors.initials: LR
authors.lastname: Gerak
authors.forename: Charles P
authors.initials: CP
authors.lastname: France
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002755:Choice Behavior / Q000187:drug effects*; D003216:Conditioning, Operant / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D007262:Infusions, Intravenous; D008253:Macaca mulatta; D008297:Male; D009293:Opioid-Related Disorders / Q000523:psychology*; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology*; D000077208:Remifentanil; D012646:Self Administration
chemical_list: D000701:Analgesics, Opioid; D010880:Piperidines; D000077208:Remifentanil
references.citation: Mol Interv. 2006 Oct;6(5):273-83
references.pmid: 17035668
references.citation: Psychopharmacology (Berl). 1992;108(3):295-300
references.pmid: 1523280
references.citation: J Pharmacol Exp Ther. 1975 May;193(2):676-88
references.pmid: 1142112
references.citation: J Exp Psychol Gen. 1999 Mar;128(1):78-87
references.pmid: 10100392
references.citation: Psychopharmacology (Berl). 2008 Sep;200(1):1-26
references.pmid: 18600315
references.citation: J Exp Anal Behav. 2006 Sep;86(2):181-95
references.pmid: 17002226
references.citation: Psychopharmacology (Berl). 2013 Sep;229(2):323-30
references.pmid: 23636304
references.citation: J Exp Anal Behav. 1974 Jul;22(1):179-96
references.pmid: 4455758
references.citation: Neuropharmacology. 2014 Jan;76 Pt B:518-27
references.pmid: 23806805
references.citation: Neuropsychopharmacology. 2003 May;28(5):919-31
references.pmid: 12637948
references.citation: J Exp Anal Behav. 1978 Sep;30(2):169-75
references.pmid: 16812096
references.citation: Psychopharmacology (Berl). 2003 Jun;167(4):424-30
references.pmid: 12690423
references.citation: Psychopharmacology (Berl). 2002 Sep;163(2):174-82
references.pmid: 12202964
references.citation: Drug Alcohol Depend. 2006 Feb 1;81(2):103-7
references.pmid: 16023304
references.citation: Pharmacol Ther. 2012 Jun;134(3):287-97
references.pmid: 22387232
references.citation: Pain Physician. 2010 Sep-Oct;13(5):401-35
references.pmid: 20859312
references.citation: Exp Clin Psychopharmacol. 2007 Jun;15(3):238-44
references.pmid: 17563210
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):189-93
references.pmid: 22015480
references.citation: Adv Pharmacol Sci. 2012;2012:281768
references.pmid: 23243420
references.citation: Drug Alcohol Depend. 1993 Dec;34(1):37-43
references.pmid: 8174501
references.citation: J Exp Anal Behav. 1967 Jan;10(1):67-74
references.pmid: 16811307
references.citation: Psychopharmacology (Berl). 2002 Oct;163(3-4):345-51
references.pmid: 12373435
references.citation: J Pharmacol Exp Ther. 2002 May;301(2):698-704
references.pmid: 11961075
references.citation: Psychopharmacology (Berl). 2006 May;186(1):99-106
references.pmid: 16568283
references.citation: Addiction. 2001 Jan;96(1):73-86
references.pmid: 11177521
references.citation: Exp Clin Psychopharmacol. 1997 Aug;5(3):256-62
references.pmid: 9260073